Related Experiment Video
Updated: Jun 7, 2026
07:46
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
Failure of vancomycin continuous infusion against experimental endocarditis due to vancomycin-intermediate
J M Entenza1, T R Veloso, J Vouillamoz
1Department of Fundamental Microbiology, Biophore-University of Lausanne, Lausanne, Switzerland. jose.entenza@unil.ch
Antimicrobial Agents and Chemotherapy
|October 20, 2010
Summary
Continuous vancomycin infusion showed limited success against experimental Staphylococcus aureus endocarditis. Higher vancomycin serum levels were needed to combat heterogeneous vancomycin-intermediate (hVISA) and vancomycin-intermediate (VISA) strains.
Area of Science:
- Pharmacology and Infectious Diseases
- Microbiology and Immunology
Background:
- Staphylococcus aureus is a common cause of infective endocarditis.
- Emergence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA (hVISA) strains poses treatment challenges.
- Optimizing vancomycin dosing strategies is crucial for effective endocarditis treatment.
Purpose of the Study:
- To evaluate the efficacy of continuous vancomycin infusion against experimental endocarditis caused by hVISA and VISA strains.
- To determine the effectiveness of specific continuous serum vancomycin concentrations (20 and 40 mg/liter).
Main Methods:
- Experimental endocarditis model in animals infected with hVISA PC1 or VISA PC3.
- Treatment with continuous vancomycin infusion for 5 days.
- Assessment of vegetation sterility at specified vancomycin serum levels.
Main Results:
- Continuous vancomycin infusion at 20 mg/liter showed minimal activity against hVISA PC1 (6/13 sterile).
- Continuous vancomycin infusion at 40 mg/liter was ineffective against VISA PC3 (2/9 sterile).
- The study demonstrated limited success of continuous vancomycin infusion against these resistant strains.
Conclusions:
- Continuous vancomycin infusion at tested concentrations was largely unsuccessful in treating experimental endocarditis caused by hVISA and VISA.
- Higher vancomycin serum concentrations or alternative treatment strategies may be necessary for these infections.
Related Concept Videos
01:25Endocarditis I: Introduction
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
01:18Endocarditis III: Medical Management
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:29Endocarditis IV: Nursing Management
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
01:25Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...